Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Use of B-type Natriuretic Peptide (BNP) to Predict Closure of a Patent Ductus Arteriosus (PDA) in Premature Infants

NCT00500305 is registered in ClinicalTrials.gov with University of Virginia as lead sponsor.

NCT NCT00500305
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00500305 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Use of B-type Natriuretic Peptide (BNP) to Predict Closure of a Patent Ductus Arteriosus (PDA) in Premature Infants
Lead sponsor
University of Virginia
Phase
Not applicable
Overall status
Completed
Start date
April 30, 2004
Completion date
March 31, 2007
Enrollment
60 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

indomethacin therapy, patent ductus arteriosus